For trade agencies, accelerators, universities, and ecosystem leaders

Sending companies to the US is easy. Getting them ready isn't.

Your region has strong health AI companies. Most will spend a year in the US learning what they could have known up front.

The lab runs that learning as a cohort, before the year is gone.

Companies leave with a US buyer thesis, claims map, evidence plan, trust packet, pilot-to-contract plan, and 90-day roadmap.

Request the host brief See how it runs

Led by Arvita Tripati. 30+ FDA-regulated, AI-enabled, and regulated health products shipped or scaled; judge for MedTech Innovator and BioTools Innovator.

Why host it

More than another pitch event

Introductions open doors. They don't tell a company which door to walk through. The lab does.

Host it when companies are asking

  • Should we enter the US?
  • Which buyer comes first?
  • Do we need FDA review?
  • Will our evidence be enough?
  • Can we sell before reimbursement?
  • What gets asked in diligence?

What hosting gives you

  • A disciplined US path for local companies.
  • Fewer expensive false starts.
  • Sharper buyer and investor conversations.
  • A pipeline ready for serious US engagement.
  • Artifacts, not applause.

How it runs

Four moves, adaptable to your calendar. The work stays the same.

1
Diagnose
Companies name the first real US beachhead, buyer, and claims posture.
2
Test the thesis
Structured buyer, investor, and advisor calls, with scripts and office hours.
3
Build the package
The answers become six artifacts they can use in market.
4
Make the ask
Each company presents a plan and a specific ask in a readiness review.
US Beachhead Memo
The first segment worth testing.
Regulatory and Claims Map
What can be said, what needs proof.
Evidence and Adoption Plan
The proof the US market needs.
Buyer Trust Packet
The materials buyers ask for.
Pilot-to-Contract Plan
A pilot built to convert.
Diligence Pack + Roadmap
A credible story and the next 90 days.

Who hosts it

Built to run with partners who already back companies eyeing the US.

  • Trade and investment agencies
  • Export promotion bodies and consular trade offices
  • Health-tech accelerators and venture studios
  • University commercialization and innovation programs
  • Corporate and investor sponsors backing regulated health

Who delivers it

Arvita Tripati, founder of Vahana Labs. 30+ FDA-regulated, AI-enabled, and regulated health products shipped or scaled, cardiac AI cleared on the Apple Watch, and work across Moderna, Gilead, the NHS, and Bristol-Myers Squibb.

She's the operator who connects every thread and pulls in named specialists, clinicians, regulatory, reimbursement, privacy, security, and investors, where a cohort needs more depth. Not more lectures. Better decisions.

Specialist network, not generic advice

The lab helps companies find the right US-entry questions, pressure-test sequencing, and know when specialist review is needed. Vahana Labs brings in a curated network of regulatory, legal, reimbursement, privacy, security, evidence, and investor specialists where useful. Formal legal, regulatory, reimbursement, tax, clinical-trial, or investment opinions should come from qualified specialists the company engages directly.

Bring the lab to your market

The host brief covers formats, what your companies build, and what hosting involves.

Request the host brief Book a call